Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5987370 | The Journal of Heart and Lung Transplantation | 2014 | 7 Pages |
Abstract
AAs are common after lung transplantation. Risk factors for developing either AF or other AAs (AFL/SVT) are different. The development of early AAs post-transplant is associated with prolonged post-operative stay and increased mortality. A rate-control strategy should be used as first-line therapy and anti-arrhythmic agents reserved for those patients who do not respond to the initial treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Carlos M. MD, Andrea M. MD, Jerry D. MD, Harish MD, Scott MD, Matthias MD, PhD, Guillermo MD, PhD,